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Defectsofeitheranosmin-1orfibroblastgrowthfactorreceptor1(FGFR1)areknowntounderliehereditaryKallmann’ssyndrome(KS),
ahumandisorderofolfactoryandgonadotropin-releasinghormone(GnRH)neuronalontogeny.Here,wereportafunctionalinteraction
betweenanosmin-1andtheFGFR1–FGF2–heparansulfatecomplex,leadingtoamplifiedresponsesintheFGFR1signalingpathway.In
human embryonic GnRH olfactory neuroblasts, wild-type anosmin-1, but not proteins with loss-of-function KS mutations, induces
neuriteoutgrowthandcytoskeletalrearrangementsthroughFGFR1-dependentmechanismsinvolvingp42/44andp38mitogen-activated
proteinkinasesandCdc42/Rac1activation.Furthermore,anosmin-1enhancesFGF2signalingspecificallythroughFGFR1IIIcinheter-
ologous BaF3 lymphoid cells in a heparan sulfate-dependent manner. Our study provides compelling evidence for anosmin-1 as an
isoform-specificco-ligandmodulatorofFGFRsignalingthatamplifiesandspecifiesFGFR1signalingresponsesduringhumannervous
systemdevelopmentanddefinesamechanismunderlyingthelinkbetweenautosomalandX-linkedKS.
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Introduction
Both olfactory and gonadotropin-releasing hormone (GnRH)-
secreting neurons originate in the nasal compartment (Tobet et
al., 2001); during development, olfactory axons establish contact
withtheolfactorybulb(OB)anlage,aprerequisiteforproperOB
formation (Graziadei and Monti Graziadei, 1986), whereas
GnRH cells follow an axonophilic migratory route toward the
hypothalamic area (Wray et al., 1989). In X-linked Kallmann’s
syndrome (X-KS), anosmia and reproductive dysfunction occur
secondarytoOBdysgenesisandhypothalamicGnRHdeficiency,
respectively (MacColl et al., 2002); initial differentiation and mi-
grationofnasalcompartmentneuronsappearnormal,thedevel-
opmental defects lying in the subsequent axonal elongation,
pathfinding, and/or terminal differentiation process. Mutations
of KAL-1 gene underlie X-KS (Franco et al., 1991; Legouis et al.,
1991). KAL-1 is expressed in the OB, cerebellum, spinal cord,
kidney, and retina during development; its encoded protein,
anosmin-1, is a secreted, extracellular matrix (ECM)-associated
glycoprotein, comprising an N-terminal cysteine-rich region, a
whey acidic protein-like four disulfide core motif (WAP), and
fourtandemfibronectintypeIII(FnIII)-likerepeats,followedby
ahistidine-richCterminus.TheWAPdomainisfoundinseveral
serineproteaseinhibitors.TheFnIIIdomains,homologoustothe
neuralcelladhesionmolecule(N-CAM)family(Robertsonetal.,
2001), show a heparan sulfate (HS) binding affinity (Hu et al.,
2004).Anosmin-1functionsasacellularadhesionorlocalguidance
molecule, stimulating axonal branching from rodent OB explants
(Soussi-Yanicostas et al., 2002) and promoting cell adhesion and
neurite outgrowth in coculture experiments (Soussi-Yanicostas et
al., 1998). In Caenorhabditis elegans, KAL-1 overexpression causes
axon branching and pathfinding defects (Bulow et al., 2002).
Fibroblastgrowthfactorreceptor1(FGFR1),amemberofthe
receptor tyrosine kinase family (Simon, 2000), has recently been
identifiedasKAL-2,aputativeautosomal-KS(A-KS)gene(Dode
et al., 2003). Involvement of FGFR signaling in organogenesis is
well documented (Coumoul and Deng, 2003). FGFs signal
throughtheirrespectivereceptorsinahighlylocalizedandregulated
mannerduringneuraldevelopment(Dono,2003).Coexpressionof
FGF2andFGFR1isdetectedinnasalepitheliumandthevomerona-
sal body (Britto et al., 2002). Targeted disruption of Fgfr1 in mouse
telencephalon results in OB aplasia (Hebert et al., 2003), whereas
micewithapartialFgf8lossexhibitasmalltelencephalonwithoutan
OB and a normal midline (Meyers et al., 1998).
Both FGFR1 and anosmin-1 require heparan sulfate proteo-
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FGF–FGFR complex formation and receptor activation
(GuimondandTurnbull,1999).Anosmin-1diffusesandbindsto
adjacent cell surfaces only in the presence of HSPG (Soussi-
Yanicostasetal.,1996).IntheKAL-1transgenicC.elegansmodel,
the anosmin-1-induced axonal branching phenotype is sup-
pressed in heparan-6O-sulfotransferase- and C5-epimerase-
deficient backgrounds (Bulow and Hobert, 2004).
Here,weshowthatanosmin-1-mediatedactivationofFGFR1
signaling induces neurite outgrowth and cytoskeletal rearrange-
mentinhumanembryonicGnRHolfactoryneuroblasts.Thetwo
KS gene products cooperate within a multimeric FGFR1–FGF2–
HSPG–anosmin-1complexleadingtofunctionalandspecificac-
tivation of FGFR1 signaling pathways involving p42/44 and p38
mitogen-activated protein kinases (MAPKs) and Cdc42/Rac1,
providing direct evidence that anosmin-1 regulates FGFR1 sig-
naling through an HS-dependent interaction.
MaterialsandMethods
FNC-B4 cell culture and neurite outgrowth assay. Isolation and propaga-
tion of primary human olfactory neuroblast culture FNC-B4 were de-
scribed previously (Vannelli et al., 1995). For neurite outgrowth assay,
7.510
3cellsthathadbeenserumstarvedfor24hrwereseededperwell
in a 96-well plate with 50 l of serum-free medium containing collagen
matrix(Chemicon,Temecula,CA)alongwithvariousrecombinantpro-
teinsandspecificinhibitors(seebelow).Aftera48hrincubationin37°C,
cells were stained with Syto Green (Molecular Probes, Eugene, OR), and
pictures of random fields were taken in a double-blind manner. The
length of the longest neurite and the cell body diameter were measured
using Lucia software (Nikon Instruments, Tokyo, Japan). Generation of
wild-type or mutant recombinant anosmin-1 proteins (Hu et al., 2004)
and FGFR1 ectodomain fused with IgFc (Anderson et al., 1998) was
described previously. Other recombinant proteins and antibodies used
were human FGF2 (Abcam, Cambridge, Cambridgeshire, UK), anti-
anosmin-1 antibody (raised against PIWF1 in our laboratory), anti-FGF2,
and anti-FGFR1 ectodomain antibody (Santa Cruz Biotechnology, Santa
Cruz, CA). To block specific signaling pathways, 20 M SU5402, (3-[3-(2-
carboxyethyl)-4-methylpyrrol-2-methylidenyl]-2-indolinone), 100 M
PD98059 (2-amino-3-methoxyflavone), and 25 M SB203580 (4-(4-
fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl) 1H-imidazole)
(Calbiochem, La Jolla, CA) were used.
Immunochemistryofembryosectionsandcells.One30-d-old[Carnegie
stage (CS) 14], two 50-d-old (CS22), and two 56-d-old (CS23) normal
human embryos were collected from chemically and surgically induced
terminations with the patients’ consent and with ethical approval from
theInstituteofChildHealthEthicalCommittee,UniversityCollegeLon-
don. Immunohistochemistry was performed on sagittal sections of
paraffin-embedded heads. The antibodies used were anti-anosmin-1,
anti-GnRH(DiaSorin,Stillwater,MA),anti-FGFR1(M2F12)endodo-
main antibody (Abcam), and anti-rabbit or anti-mouse secondary anti-
body conjugated with either Texas Red or FITC (Jackson ImmunoRe-
search, West Grove, PA). For double immunohistochemistry using
streptavidin–biotin–peroxidase and alkaline phosphatase methods, sec-
tions pretreated with 3% hydrogen peroxide were blocked with 5% nor-
malgoatserum(NGS)inPBSwith0.5%Triton-X(PBST)andincubated
overnight with anti-anosmin-1 antibody. After washing with PBST, they
were incubated with biotin-sp-conjugated AffiniPure anti-rabbit goat
IgG antibodies, washed, and incubated with peroxidase-conjugated
streptavidin complex (Jackson ImmunoResearch). To visualize the per-
oxidase activity, sections were washed in PBST and 0.05 M Tris-HCl, pH
7.6, before incubation in 0.05 M Tris-HCl, pH 7.6, containing 0.025%
3,3-diaminobenzidinetetrahydrochloride(Sigma,St.Louis,MO).After
a wash, incubation with levamisole to inhibit endogenous alkaline phos-
phataseactivity,andblockingin5%NGS,sectionswereincubatedagain
overnight with either anti-GnRH or anti-FGFR1 endodomain antibod-
ies. They were then washed and developed with the appropriate alkaline
phosphatase-conjugated secondary antibodies and Fast Red (Dako Cy-
tomation, Cambridge, Cambridgeshire, UK) in 1 mM levamisole solu-
tion. To confirm the specificity of the antibodies, corresponding control
reactions were also performed by preincubating the primary antisera
with its corresponding antigen (in the case of anosmin-1), using preim-
mune antisera, or omitting primary or biotinylated antisera.
To visualize cell surface-associated recombinant anosmin-1 in
FNC-B4 cells in the presence or absence of HS, serum-starved cells were
incubatedfor24hrwith1nMPIWF1,withorwithoutpreviousaddition
of 100 g/ml HS (Sigma-Aldrich, St. Louis, MO). Immunocytochemis-
try using anti-anosmin-1 antibody was performed under nonpermeabi-
lizing conditions. For cytoskeletal filamentous-actin (F-actin) and vin-
culin staining, 2  10
3 cells were seeded in chamber slides with serum-
free medium containing either 100 nM bovine serum albumin (BSA), 1
nM PIWF4, or 1.5 nM FGF2. After 48 hr in 37°C, cells were stained with
TexasRed-conjugated phalloidin and a vinculin monoclonal antibody,
followed by anti-mouse FITC-conjugated secondary antibody incuba-
tion.PicturesweretakenusingeitherAxioplan(Zeiss,Oberkochen,Ger-
many) and TCS SP2 confocal (Leica, Nussloch, Germany) microscopes
or an Axioplan 2 bright-field/fluorescence microscope (Zeiss).
Western blot, coimmunoprecipitation, and pull-down assay. For West-
ern blot analysis of MAPKs, FNC-B4 cells were serum starved for 24 hr
before being stimulated with 1 nM PIWF4, 1.5 nM FGF2, or 10% fetal
bovineserum.Cellswerethenharvestedatvarioustimepoints,andtotal
cell lysates were prepared in lysis buffer (1% Triton X-100, 50 mM Tris
HCl, pH 8.0, and 150 mM NaCl) containing inhibitors of proteases and
phosphatases. The phosphorylation status of p42/44, p38, and c-Jun
NH2-terminal kinase (JNK) MAPKs were analyzed by using
phosphorylation- or nonphosphorylation-specific antibodies (Cell Sig-
naling, Beverly, MA). For immunoprecipitation, total cell lysates from
serum-starved FNC-B4 cells were prepared in buffer containing 50 mM
HEPES,pH7.4,150mMNaCl,1.5mMMgCl2,1m MEGTA,10%glycerol,
1% Triton X-100, 50 mM NaF, 1 mM Na3VO4,1m M phenylmethylsulfo-
nylfluoride,and1.9g/mlaprotinin.Thepreclearedcelllysates(1.5mg)
with or without the addition of 500 ng of PIWF4 were immunoprecipi-
tatedwith1.5gofanti-FGFR1endodomainantibodyovernightat4°C.
Samples were then washed in buffer containing 20 mM HEPES, pH 7.4,
150 mM NaCl, 0.1% Triton X-100, and 10% glycerol and analyzed by
Westernblottingusinganti-His(Invitrogen,Paisley,UK),anti-HS(10E4
epitope; Seikagaku America), anti-FGFR1 ectodomain, and anti-FGF2
antibodies. As positive controls, 50 ng of PIWF4 and 50 g of total cell
lysate were loaded per lane. For the pull-down assay, the Rac/Cdc42
activation assay kit (Chemicon) was used according to the manufactur-
er’s protocol. Recombinant glutathione S-transferase (GST)–p21-
activated kinase 1 (PAK1) was detected using anti-GST antibody (Phar-
macia/Pfizer, Peapack, NJ).
Reverse transcription-PCR. Total RNA extracted from FNC-B4 cells
using TRIzol (Invitrogen) was reverse transcribed using the First-Strand
cDNA Synthesis kit (Amersham Biosciences, Piscataway, NJ). The PCR
primer sequences and parameters for different FGFR isoforms, KAL-1,
GnRH-1, and -actin are available as supplemental material at
www.jneurosci.org.
BaF3 cell proliferation assay. BaF3 cells expressing the IIIc isoforms of
FGFR1,FGFR2,orFGFR3werekindlyprovidedbyDavidOrnitz(Wash-
ington University, St. Louis, MO) and maintained as described previ-
ously(Ornitzetal.,1996).Forproliferationassays,10
4cellsperwellwere
plated in a 96-well plate with 100 l of culture medium [RPMI 1640
supplemented with 10% fetal calf serum, 2 mML -glutamine, and antibi-
otics,withoutinterleukin-3(IL-3)]andincubatedwith2ng/mlIL-3(R&
D Systems Europe, Abingdon, Oxon, UK) or recombinant human FGF2
(R&DSystemsEurope)andporcineintestinalmucosaheparin(Sigma),
alongwiththeindicatedconcentrationsofanosmin-1.After72hrat37°C,a
cell proliferation assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide (MTT) was performed as described previously
(Guimond and Turnbull, 1999).
Statisticalanalysis.Statisticalsignificanceatp0.01wascalculatedby
Student’s t test from three independent experiments (see Fig. 3B) and
one-way ANOVA with the Dunnett test for multiple comparisons from
five independent experiments using SPSS (Chicago, IL) 10.0 software
(see Fig. 3C).
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Expressionofanosmin-1,FGFR1,andGnRHinthehuman
olfactory compartment
OlfactoryandGnRHprogenitorcellsfirstappearintheolfactory
placode (OP) and subsequently migrate toward the rostral fore-
brain(Schwanzel-FukudaandPfaff,1989).Ourimmunofluores-
cenceanalysisconfirmedthepresenceofanosmin-1,FGFR1,and
GnRHinhumanembryonicOPasearlyas4.5weeks(CS14)(Fig.
1A,B). GnRH- and FGFR1-positive cells were distributed along
the OP, but only the cells in the medial region coexpressed both
proteins, albeit at low levels (Fig. 1A, arrowheads). Investigation
of anosmin-1 and FGFR1 distribution in an adjacent section re-
vealed their presence along the OP (Fig. 1B). At 7 weeks (CS22),
neitherGnRHcellsnoranosmin-1couldbedetectedintheolfac-
tory epithelium (OE) (Fig. 1C,D), and only GnRH-expressing
cellswerefoundintheterminalnerve(TN)(Fig.1C);theabsence
of anosmin-1 at this phase of development has been described
previously (Hardelin et al., 1999). At 8 weeks of development
(CS23), expression of both anosmin-1 and FGFR1 was found in
theTN(Fig.1E,F),doubleimmunohistochemicalanalysisofthis
regionindicatingthattheywerepresentlyclosetoeachother(Fig.
1E). Investigation of anosmin-1 and GnRH expression on an
adjacent section of the TN (Fig. 1G,H) again shows the expres-
sion of both in this region (Fig. 1G). These data support a poten-
tial in vivo interaction between FGFR1 and anosmin-1 at these
sites during olfactory GnRH system development.
CharacterizationofFNC-B4 cells
FNC-B4 cells are primary neuroblast cultures derived from the
human fetal olfactory neuroepithelium. These cells express sev-
eral olfactory and neuron-specific markers including neurofila-
ment,N-CAM,NSE(humanneuron-specificenolase),OMP(ol-
factory marker protein), Golf (olfactory-specific GTP-binding
protein  subunit), OCNC (olfactory cyclic-nucleotide-gated
channel), and Olf-1 (olfactory transcription factor-1) (Vannelli
et al., 1995). They also express GnRH and GnRH receptor and
respondtoautocrineGnRHstimulation(Romanellietal.,2004).
They therefore represent premigratory neuronal precursor cells
that retain properties of both olfactory and GnRH neurons. We
investigated FGFR expression in these cells by using isoform-
specific PCR primers and demonstrated that both the b and c
isoformsofFGFR1andFGFR3,butonlythebisoformofFGFR2,
werepresent(Fig.1A).Expressionoftheircognateligands,FGF1
andFGF2,wasalsoconfirmedbyWesternblotting,implyingthat
FGFR pathways are functionally used in these cells (Fig. 1B).
However,anosmin-1couldnotbedetectedbyreversetranscription
(RT)-PCR (Fig. 1C) or immunocytochemistry (data not shown).
FNC-B4 cells thus provide a model system to investigate whether
anosmin-1hasaneffect(s)onFGFR1-mediatedsignalingeventsthat
may occur during olfactory GnRH system development.
Anosmin-1inducesneuriteoutgrowthinFNC-B4 cells
We recently generated a Drosophila S2 cell line enabling a rela-
tively large-scale production of purified recombinant anosmin-1
protein (Fig. 2). PIWF4 represents the full-length wild-type
anosmin-1 with four FnIII domains, whereas the truncated ver-
sion, PIWF1, contains just one. Two other mutant derivatives,
designatedasmPIWF4andmPIWF1,incorporatedaC172Rmu-
tation identified in three X-KS-affected brothers, which disrupts
one of the four disulfide core motifs in the WAP domain (Rob-
ertson et al., 2001).
To test the effect of anosmin-1 on neuronal differentiation of
FNC-B4 cells, we established a three-dimensional collagen ma-
trix culture system and examined the phenotypic changes in-
ducedbyanosmin-1.Cellswithoutanytreatmentortreatedwith
100 nM BSA exhibited a mainly round or fusiform shape with
short neurites and undefined patterns of branching. In contrast,
cells treated with 1–10 nM anosmin-1 showed more spindle-
shaped bipolar and occasionally multipolar morphology with
longer neurite extensions and axonal branching (Fig. 3A). Treat-
mentwith1.5nMrecombinanthumanFGF2alsoinducedacom-
parable neurite outgrowth phenotype. We then determined the
dose dependency of the anosmin-1 effect and whether the X-KS
mutantsstillretainthisability.Cellswereincubatedwithvarying
concentrations of PIWF4, mPIWF4, PIWF1, or mPIWF1, and
the mean length of the longest neurite was statistically compared
with that of BSA treatment. PIWF4 caused a significant increase
of neurite length in a dose-dependent biphasic manner that
peaked ata1n M concentration ( p  0.05). PIWF1 showed sim-
ilareffects,whereasthetwoWAPdomainmutants,mPIWF4and
mPIWF1,didnot(Fig.3B).Tofurtheranalyzethisphenomenon,
wemeasuredtheratiobetweenthelongestneuritelengthandcell
body diameter and calculated the percentage of cells with a par-
ticularratio.InBSA-treatedculture,only20%ofcellshadneu-
riteslongerthanfourtimesitscellbody,butaftertreatmentwith
1.5 nM FGF2 or 1 nM PIWF4, it increased to 40% ( p  0.01).
Thus, anosmin-1 could induce responses equivalent to those
achieved by the addition of relatively high concentrations of ex-
ogenous FGF2. Again, PIWF1 behaved similarly to PIWF4,
whereas mPIWF1 or PIWF1 preincubated with its neutralizing
antibody showed the same level as that of BSA treatment. There
was no additional increase when FGF2 and PIWF1 were added
together,possiblyindicatingthesaturationoftheavailablerecep-
tors(Fig.3C,D).Thus,anosmin-1inducesneuriteoutgrowthina
dose-dependentmanner;althoughanintactWAPdomainisnec-
essaryforthiseffect,onlyoneFnIIIdomainissufficient.Because
PIWF1 is indistinguishable from the wild-type PIWF4 in these
assays, we pursued our studies using PIWF1, which generated a
better yield of recombinant protein production.
We next asked whether the FGFR1 signaling pathway is in-
volved in the anosmin-1-induced phenotype and repeated the
assayinthepresenceofFGFR1-specificinhibitors.Preincubation
of cells with an anti-FGF2 antibody or the FGFR1 antagonist
SU5402 (Mohammadi et al., 1997) blocked FGF2-induced neu-
rite outgrowth. Importantly, the effect of PIWF1 was also inhib-
ited by SU5402 and anti-FGFR1 antibody. Moreover, the addi-
tion of FR1FC, a soluble recombinant FGFR1 ectodomain
(Anderson et al., 1998), competed off the PIWF1 effect. Taken
together, these data indicate that the anosmin-1 effect is depen-
dentonFGFR1,especiallytheavailabilityofitsectodomain,sug-
gesting a role for anosmin-1 in modulating the extracellular li-
gand–receptor interaction (Fig. 3C,D). It is not possible to
conclude, however, whether anosmin-1 directly interacts with
theFGFR1orindirectlycooperateswithotherligandstoenhance
thesignaling,becauseFNC-B4cellsconstitutivelyexpressendog-
enous FGF1 and FGF2, which may work by autocrine and para-
crine mechanisms (Fig. 1B) (Ensoli et al., 1998).
Anosmin-1physicallyinteractswith
FGFR1–FGF2–HSPG complex
To understand the nature of anosmin-1–FGFR1 interaction, we
performed a coimmunoprecipitation assay using an FGFR1
endodomain antibody. Western blot analysis of the immune
complex shows FGFR1 coprecipitates with endogenous FGF2.
From the several endogenous HSPG species present in the total
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are also coprecipitated, indicating the presence of the FGFR1–
FGF2–HSPG complex. When recombinant anosmin-1 was
addedtothelysate,itwasalsobroughtdownwithinthiscomplex
as detected by an anti-His antibody, consistent with a direct in-
teraction of anosmin-1 with the FGFR1–FGF2–HSPG complex.
ThefactthatalthoughtheamountofFGF2withinthecomplexis
maintained,moreHSPGseemstobeintegratedwhenanosmin-1
is present suggests a role of anosmin-1 in the formation of this
complex(Fig.4A).Anosmin-1isaHS-bindingprotein,andithas
been suggested that membrane-associated HSPGs might immo-
bilize anosmin-1 to the cell surface (Soussi-Yanicostas et al.,
1996). Immunocytochemistry of FNC-B4 cells incubated with
anosmin-1 confirmed cell membrane adhesion of this protein,
accompanied by concomitant induction of neurite outgrowth.
TheadditionofexogenousHScauseddissociationofanosmin-1,
likely because of competitive inhibition of binding to endoge-
nous HS (Fig. 4B), resulting in loss of the neurite outgrowth
phenotype. Taken together, these data support, although do not
prove, the notion that there is an obligatory requirement of HS
for the biological action of anosmin-1.
Anosmin-1-inducedMAPKactivationisrequiredfor
neurite outgrowth
We next questioned whether the formation of an anosmin-1–
FGFR1–FGF2–HSPG complex activates a functional FGFR1 sig-
naling pathway and assessed the activation of FGFR1 down-
stream effector MAPKs. FNC-B4 cells were growth arrested in
serum-free medium for 24 hr and stimulated with either 1 nM
anosmin-1or1.5nMFGF2.Cellswerethenharvestedatdifferent
time points and analyzed by Western blotting with
phosphorylation-specific p42/44(ERK), p38, or JNK antibodies.
Both anosmin-1 and FGF2 induced maximum phosphorylation
of p42/44 and p38 within 30 min, which gradually decreased to
basal level after 6 hr, whereas total p42/44 and p38 levels re-
mained relatively constant (Fig. 4C). In contrast, no phosphory-
4
tates; white arrowheads) in the TN. F, Flourescence image of E, confirming the expression of
FGFR1 (red). G, Double immunohistochemistry on an adjacent serial section of E, showing
anosmin-1(brownDABprecipitates;blackarrowheads)andGnRH(crimsonFastRedprecipi-
tates;whitearrowheads)intheTN.H,FlourescenceimageofG,confirmingtheexpressionof
GnRH(red).Scalebar:(inA)A,B,100m;C,D,200m;E–H,15m.r,Rostral.Allsectionsare
showninsagittalorientation.I,K,AnalysisofFNC-B4cellsusingRT-PCRshowsthepresenceof
GnRH and different FGFR isoforms but no anosmin-1. -Actin and no DNA were included as
positiveandnegativecontrols.J,ExpressionofthreedifferentformsofFGF1andFGF2proteins
aredetectedinFNC-B4cellsbyWesternblotting,suggestingtheexistenceofafunctionalFGFR1
andGnRHpathway.Molecularweightmarkersareshown.
Figure1. Expressionofanosmin-1,FGFs,FGFRs,andGnRH.A,Immunohistofluorescenceof
a4.5-week-oldhumanembryoOPshowingFGFR1(FITClabeling)andGnRH(TexasRedlabel-
ing)proteindistribution.Yellowarrowheadsindicatesitesofcoexpressionoftheseproteinsin
themedialregionoftheOP.B,Theadjacentserialsection,7mdownfromA,showingFGFR1
(FITC labeling) and anosmin-1 (Texas Red labeling) distribution in the OP. C, Section of a
7-week-old embryo showing the OE and TN area. The figure shows the presence of GnRH-
immunoreactivecellsinclustersonlywithintheTN(whitearrowheads).D,Theadjacentserial
sectionofC,labeledwithanti-anosmin-1antibody,showstheabsenceofanosmin-1intheOE
at this stage. E, Double immunohistochemistry of an 8-week-old embryo section, showing
anosmin-1(brownDABprecipitates;blackarrowheads)andFGFR1(crimsonFastRedprecipi-
Figure 2. Schematic representation of the structure of recombinant anosmin-1 proteins
producedinS2cells.PIWF4representsthewild-typeanosmin-1,whereasPIWF1isatruncated
formwithonlyoneFnIIIdomain.TheWAPdomainC172Rpointmutation(star)ispresentonly
inmPIWF4andmPIWF1.CR,Cysteine-richregion;H,histidine-richregion;V5,V5epitopetag
derivedfromSimianvirus5;6His,6histidinetag.
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sates, excluding the possible involvement
of this pathway (data not shown). These
resultsindicatethatbindingofanosmin-1
toFGFR1–FGF2–HSPGonthecellsurface
amplifies the FGFR1 signaling pathway re-
sponse to endogenous FGF2, resulting in
sustained phosphorylation of both p42/44
and p38 MAPKs. We next asked whether
MAPK activation was required for
anosmin-1-induced neurite outgrowth by
conducting the assay in the presence of spe-
cific MAPK antagonists. The anosmin-1 ef-
fect was blocked by the addition of the
MAPK kinase (MEK) inhibitor PD9859
(Pang et al., 1995) and the p38 inhibitor
SB203580 (Iwasaki et al., 1999), indicating
that these MAPKs mediate anosmin-1 ef-
fects (Fig. 3C,D).
Anosmin-1causesactincytoskeleton
reorganizationviaCdc42–Rac1 pathway
Both neurite outgrowth and neuronal mi-
gration require the organized polymeriza-
tion of F-actin to drive the forward cell
membraneextension.Wethereforedeter-
mined whether anosmin-1 caused any
changesinactincytoskeletalorganization.
Immunofluorescence staining of F-actin
and vinculin in FNC-B4 cells revealed
that incubation with either FGF2 or
anosmin-1, but not BSA, caused changes
in the actin cytoskeleton within the cell
soma and the growth cone, exhibiting
filopodia and microspike formation with
associated adhesion foci and complexes
(Fig.5A).BSA-treatedcellsshowedasmall
number of stress fibers in the periphery of
the cell, whereas after FGF2 and
anosmin-1 treatments, a slightly greater
number of stress fibers were observed.
Scarce related focal adhesion complexes
associated with actin arrays were also ob-
served (Fig. 5A). Lamellipodium forma-
tion could not be detected in these cells,
consistentwithpreviousreportsinhuman
neuroepithelioma cells in which FGF2
failed to induce lamellipodium formation
(vanWeeringetal.,1998).TheRhofamily
of GTPases are one of the FGFR1 down-
stream effectors and the principal regula-
tors of actin cytoskeletal rearrangements
(Nikolic, 2002). We asked whether the
anosmin-1-induced activation of the
FGFR1 signal pathway also led to activa-
tion of the Rho family, particularly Cdc42
and Rac1. Because only the GTP-bound
activated form of Cdc42 and Rac1 bind to
their common downstream effector
PAK1, we used the highly conserved p21-
binding domain (PBD) of PAK1 (Daniels
et al., 1998; Iwasaki et al., 1999) conju-
gated to agarose beads to pull down the
Figure3. Anosmin-1inducesneuriteoutgrowthviaFGFR1andMAPKsignalingpathways.A,MorphologyofFNC-B4cellsin
three-dimensionalcollagenculturetreatedwithBSA,FGF2,oranosmin-1proteins.Scalebar,5m.B,Dose-dependenteffectsof
wild-typeormutantanosmin-1recombinantproteinsonthemeanlengthofthelongestneurites.ValuesarethemeanSE.p
0.01 compared with the BSA control (*) or between different protein concentration (**) are indicated; n  1000 for each
independentexperiment.C,D,Theneurite/somaratioofcellsafterindicatedtreatments.C,Thepercentageofcellsexhibitinga
neurite/somaratio3(3),between3and4(4),orhigherthan4(4)aftereachtreatmentareshowninthegraph.Average
valuesSEfromfiveindependentexperimentsareshown.Statisticalcomparisonhasbeencomputedbetweenthe4groupof
differenttreatmentandthatofBSAcontrol(*p0.01)andbetweenthe3groupofdifferenttreatmentandthatofBSAcontrol
(**p  0.01). There was no significant difference among 4 groups. D, The average percentage  SE along with the actual
numbersofcells(inparentheses)exhibitingtheindicatedneurite/somaratioarealsoshownasatable.
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was performed on the eluted protein complexes and the band
intensity was analyzed by densitometry, cells stimulated with ei-
therFGF2oranosmin-1showedahigherlevelofCdc42-GTPand
Rac1-GTP, compared with that of BSA treatment, indicating
thesepathwaysarealsoinducedbyanosmin-1signalingandsup-
port the actin reorganization in these cells (Fig. 5B).
In summary, these results provide compelling evidence that
Figure 4. Association of anosmin-1 with FGFR1/FGF2/HSPG on the cell surface induces
MAPK phosphorylation. A, Western blot analysis of FGFR1 immunoprecipitation (IP) using
FNC-B4 cell lysates with (Anosmin) or without (	Anosmin) the addition of exogenous
anosmin-1.Recombinantanosmin-1aloneortotalcelllysatewasincludedasacontrol.From
thedifferentspeciesoftheendogenousHSPGspresentinthetotalcelllysate,thetwomajor
bandsrecruitedinthecomplexaremarkedwitharrows.Proteinmolecularweightmarkersare
indicated. B, Immunofluorescence images demonstrating that cell-surface association of
anosmin-1ismediatedbyHS.Panelsshowcellsurface(cs)-associatedproteinandcorrespond-
ingphase-contrast(pc)imageofthesamecellwithorwithouttheadditionofHS.Scalebar,5
m.C,Phosphorylationstatusofp42/44andp38MAPKwereanalyzedbyWesternblottingat
theindicatedtimepointsaftertheadditionofanosmin-1orFGF2inserum-starvedcultures.The
levelsoftotalp42/44andp38proteinsarealsoshown.CellsgrowninserumcontainingF-12
medium(S)wereincludedasapositivecontrol.
Figure5. Anosmin-1causescytoskeletonreorganizationthroughCdc42–Rac1pathway.A,
Vinculin(FITClabeling;greenarrows)andphalloidin(TexasRedlabeling)stainingrevealsor-
ganizationofactincytoskeletoninFNC-B4cellsafterBSA,FGF2,oranosmin-1treatments.Left,
Individual cells exhibiting F-actin stress fibers (Sf) after different treatments. Right, F-actin
reorganizationformingfilopodia(Fil)andmicrospikes(Ms)inthegrowthcones,accompanied
byadhesioncomplexes(Fc)andfocaladhesion(Fa).Scalebars:left,10m;right,5nm.B,The
activated(GTP-bound)Cdc42orRac1proteinsarepulleddownbyGST–PAK1–PBD-conjugated
agarose beads and analyzed by Western blotting. The level of GST–PAK1–PBD is shown as
loadingcontrol.Intensityofthebandsunderdifferenttreatmentsisquantifiedbydensitome-
try,andthefoldofincreasewithrespecttoBSAisindicated.Thevaluesarenormalizedtothe
GST–PAK1–PBDlevels.
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tion-relatedphenotypicchangesinFNC-B4
cells by activating FGFR1 and its down-
streamsignalingpathways.Nonetheless,the
exactrequirementsforanosmin-1activityin
enhancing the FGFR1/FGF2 signaling were
stillunclear.Alternativesplicingoftheextra-
cellular Ig-like domains generates different
FGFRisoformswithspecificligand-binding
properties in a tissue-specific manner
(GrothandLardelli,2002).FNC-B4cellsex-
press a range of other FGFR isoforms and
ligands; other cell type-specific factors
presentinFNC-B4cellsmightalsoinfluence
the action of anosmin-1. To clarify these is-
sues,weusedaheterologousBaF3lymphoid
cell system in which the activity of anos-
min-1 on specific FGFR isoforms can be directly tested in the pres-
ence or absence of HS.
Anosmin-1enhancesFGF2/FGFR1signalinginBaF3 cells
BaF3 is a mouse B-cell lineage dependent on IL-3 for its growth
andsurvival(PalaciosandSteinmetz,1985).Theydonotexpress
endogenous FGFRs or HSPGs and do not proliferate in response
to FGF2 or heparin alone (data not shown). BaF3 derivatives
transfected with single isoforms of the each FGFR have been en-
gineered. In the absence of IL-3, these cells rely on FGFR activa-
tionbyexogenousFGFandHS;thus,specificityofvariousligan-
d–receptor interactions can be assessed by measuring their
relativemitogenicactivity(Ornitzetal.,1996).Wefirstexamined
theeffectsofanosmin-1inFGFR1IIIc-transfectedBaF3cellsbya
colorimetric MTT assay. Increasing amounts of anosmin-1, ei-
theraloneorincombinationwithasuboptimalconcentrationof
FGF2(300pM)orheparin(300ng/ml)individuallydidnotshow
any effects on proliferation, indicating that anosmin-1 cannot
directly substitute for any of the molecules normally involved in
FGFsignaling.Anosmin-1didnotenhancethemitogenicactivity
of IL-3 (Fig. 6A). In the presence of both FGF2 and heparin,
however, the addition of anosmin-1 caused a significant and
marked dose-dependent increase in cell proliferation (Fig. 6A).
Therefore, in the presence of anosmin-1, FGFR1 IIIc-mediated
mitogenic responses to particular concentrations of FGF2 are
amplified. HS was sufficient to mediate this effect, excluding the
possible requirement for other neuronal cell type-specific ele-
ments. Enhancement of proliferative responses were even ob-
served with higher concentrations of FGF2 (1 nM) and heparin
(10 g/ml) that would normally generate a maximal FGFR-
mediated response in these cells (Fig. 6B). These supramaximal
responses clearly support the notion that anosmin-1 acts to am-
plify signaling responses to particular concentrations of FGF2.
Furthermore, our findings in FNC-B4 cells in which anosmin-1
alonewaseffectivewithouttheadditionofexogenousFGF2(Figs.
3, 4C, 5) are also consistent with a mechanism that involves aug-
mentation of responses to endogenous levels of FGF2.
Because FGF2 is a potent activator of mostly the c isoforms of
all FGFRs (Ornitz et al., 1996) and FNC-B4 cells express multiple
isoforms of FGFR1, FGFR2, and FGFR3, we investigated whether
anosmin-1 could differentially modulate FGFR isoforms.
Anosmin-1wasunabletoinduceproliferationofcellsexpressing
FGFR2 IIIc or FGFR3 IIIc under similar conditions (Fig. 6B).
Therefore, at least for the c isoforms, anosmin-1 is a FGFR1-
specific modulatory co-ligand that enhances FGF2 signaling.
However, the truncated anosmin-1, PIWF1, failed to induce a
significant increase in cell proliferation, suggesting that all four
FnIII domains of anosmin-1 are required to activate FGF2/
FGFR1 IIIc signaling in this cell system (Fig. 6C).
Discussion
During early neuronal development, olfactory axons and GnRH
neurons travel through diverse embryonic compartments and
undergo different morphological and physiological changes. A
body of evidence suggests that ECM proteins, cell adhesion mol-
ecules,growthfactors,andchemotacticfactorsparticipateinreg-
ulating neural cell behavior and morphology, thus determining
how cells respond to their environment. It has been suggested
that anosmin-1 is an adhesion molecule for different neuronal
and non-neuronal cell types and may modulate neurite out-
growth in a cell type-specific manner (Soussi-Yanicostas et al.,
1998). The identity of the cell surface receptor(s) for anosmin-1,
however,hasbeenunknown,anditwasspeculatedthatHSmight
be a cofactor stabilizing anosmin-1 binding. Our study shows
that anosmin-1 acts as an FGFR1-specific modulatory co-ligand
that physically interacts with the FGFR1–FGF2–HSPG complex
and amplifies the resulting downstream signaling responses. In
human embryonic olfactory GnRH neuroblasts, anosmin-1-
mediated activation of the FGFR1 pathway induced neurite out-
growth and cytoskeletal reorganization. This occurred via sus-
tained MAPK phosphorylation and Cdc42/Rac1 activation, at
levels equivalent to or higher than those induced by the addition
of high concentrations of exogenous FGF2. In the presence of
anosmin-1, therefore, the level of cellular responses to particular
concentrations of FGF2 is increased. Our results using BaF3 cells
indicate that anosmin-1 effect is specific to the FGFR1 IIIc iso-
form,althoughadditionalworkisclearlywarrantedtoevaluatea
potential role for anosmin-1 in regulating the IIIb isoforms.
Our investigation on the spatiotemporal distribution of
GnRH/anosmin-1/FGFR1 during early human brain develop-
mentfurthersupporttheseinvitroobservationsandsuggesttheir
possible functional interaction in vivo. We have demonstrated
thepresenceofanosmin-1andFGFR1intheOPregionwherethe
pioneerGnRHneuronslie.Lateronat7weeks,whentheOPhas
developed into OE and the GnRH neurons have migrated, nei-
theranosmin-1norFGFR1expressioncouldbefoundintheOE.
One week later, the presence of anosmin-1 along with FGFR1-
and GnRH-expressing cells within the TN region was evident.
This is the first time an 8-week-old embryo has been studied for
theseproteins.Previousstudiesinhumanhaveshownanosmin-1
expressionintheOBpresumptiveregionfromweek5onward.It
hasbeenalsodetectedinthemedialwallsoftheprimitivecerebral
Figure6. Anosmin-1enhancesFGF2signalingthroughFGFR1IIIcinBaF3cells.A,ProliferationcurveofBaF3cellsexpressing
FGFR1IIIcwithincreasingamountsofPIWF4undersuboptimalconcentrationsofFGF2(300pM;F),heparin(300ng/ml;E),or
both( ).Cellproliferationinthepresenceof1ng/mlIL-3andPIWF4isalsoshown(ƒ).B,TheeffectofPIWF4ontheproliferation
ofBaF3cellsexpressingFGFR1IIIc(F),FGFR2IIIc(E),orFGFR3IIIc( )incubatedwithoptimalconcentrationsofbothFGF2(1nM)
and heparin (10 g/ml). C, Proliferation curve of BaF3 cells expressing FGFR1 IIIc with an increasing amount of PIWF1 (E)o r
PIWF4( )underoptimalFGF2andheparinconcentrations(asinB).
10390 • J.Neurosci.,November17,2004 • 24(46):10384–10392 Gonza ´lez-Martı ´nezetal.• ModulationofFGFR1SignalingbyAnosmin-1hemisphereswithinthelatermigratoryroutesofGnRH-releasing
neurons (Hardelin et al., 1999). In the musk shrew, anosmin-1 is
demonstrable in the OB, but it is also detected in the OE, the
frontonasalregionalongtheextracerebralcourseoftheolfactory,
vomeronasal, and TN fibers, all of which are associated with mi-
grating GnRH neurons (Dellovade et al., 2003). Furthermore,
recent studies in mouse by Gill et al. (2004) support the conten-
tion that FGFR1 signaling is involved in early GnRH neuronal
fate as well as migration. Combined with our current data, these
observations suggest a permissive or instructive role of FGFR1/
FGF2/anosmin-1-mediated signaling during olfactory GnRH
neuronal establishment. Thus, disruption of anosmin-1/FGFR1
signaling events would be expected to contribute to the patho-
genesis of KS. In the X-linked form of this disorder, early GnRH
and olfactory neuronal development appears intact, suggesting
thatthediseasephenotyperepresentsadisturbanceoflaterbulb/
GnRHneuronalontogeny.Therefore,itispossiblethatanosmin-
1/FGFR1 signaling events demonstrated here are similarly in-
volved in bulb histogenesis proper and/or the establishment of
neuronal connectivity between incoming olfactory sensory neu-
rons and mitral cells within the bulb. Anosmin-1-mediated
FGFR1 signaling may also be involved in mitral cell proliferation
and survival, as well as outgrowth of collaterals from the mitral
and tufted cell axons to the olfactory cortex, as demonstrated
previously (Soussi-Yanicostas et al., 2002).
Toourknowledge,anosmin-1isthefirsthumanproteiniden-
tified as a positive regulator of FGFR1 signaling through an
isoform-specific mechanism, the loss of which is associated with
a clinical disorder. There are, thus far, few factors known to in-
crease FGFR1 activity by extracellularly interacting with its
ectodomain (Tsang and Dawid, 2004). Sef (Tsang et al., 2002)
and XFLRT3 (Bottcher et al., 2004) are transmembrane proteins
containing extracellular FnIII domains. Sef, first identified in ze-
brafish, inhibits FGFR signaling by preventing FRS2 phosphory-
lation, and Sef-b, the cytoplasmic isoform, blocks MEK activity.
On the other hand, XFLRT3 promotes FGF8 signaling through a
FnIIIdomain-mediatedinteractionwithFGFR1inXenopusbyas
yet unknown mechanisms. Although there is no evidence that
any of these factors is related to anosmin-1, it is plausible that there
are multiple regulators of the FGF signaling pathway expressed in
specificspatiotemporalpatternsindifferentcelltypesusingdifferent
modes of action. These molecules may represent an additional level
of complexity in the network of molecules involved in regulation of
FGFR signal transduction during development.
It has been suggested that cells are capable of sensing the dif-
ferences in duration and intensity of extracellular signals trigger-
ing different effector pathways accordingly and that p42/44
MAPK phosphorylation may be the cellular interpretation ma-
chinery (Marshall, 1995; Harada et al., 2001). Our data in
FNC-B4 cells show that anosmin-1- and FGF2-mediated FGFR1
signaling results in sustained MAPK phosphorylation that is
maintained over a few hours. The MAPK pathway has been im-
plicated in neurite outgrowth in different neuronal cell lines
(Pang et al., 1995; Iwasaki et al., 1999); in PC12 cells, sustained,
but not transient, phosphorylation of p42/44 can induce growth
arrest and differentiation. Studies have shown that only this type
of MAPK activation results in p35 induction, a neuron-specific
activatorofcyclin-dependentkinase(cdk)5(Haradaetal.,2001).
The Rho family of small GTPases regulates actin-based cellular
motility during neuronal differentiation. Typically, Cdc42 and
Rac1 induce, whereas RhoA inhibits, neurite outgrowth. The
neuron-specific expression and cell membrane association of
PAK1, a downstream effector of both Rac1 and Cdc42, induces
cytoskeletal changes, and its role during neurite outgrowth and
axonal pathfinding is established (Nikolic, 2002). One of the ef-
fector kinases regulated by Rac1 is p35. cdk5/p35 kinase activity,
whichmodulatesPAK1function(Nikolicetal.,1998),isinduced
only in differentiating neuronal cells (Nikolic, 2002). In
anosmin-1-treatedFNC-B4cells,wedemonstratedthatRac1and
Cdc42wereactivatedandboundtoPAK1,suggestingtheseeffec-
tor pathways may be responsible for the anosmin-1-induced re-
organization of F-actin and neurite outgrowth.
Several speculations can be made regarding the possible
mechanism of action of anosmin-1 within the FGFR1–FGF2–
HSPG signaling complex. Anosmin-1 may facilitate receptor
dimerization and stabilize the assembly in conjunction with
HSPG,increasingthedurationorintensityofthesignal.Alterna-
tively, anosmin-1 may anchor onto FGFR1 to attract FGF2 and
HS for rapid receptor recognition. Our data do not preclude a
direct interaction of anosmin-1 with FGFR1, although the disso-
ciation of anosmin-1 from cells in the presence of exogenous HS
(Fig. 4B) is consistent with either a weak anosmin-1–FGFR1 in-
teractionoraninteractionthatisstronglyHSdependent.Itisalso
possible that anosmin-1 determines the specificity of HS being
recruitedduringcertaindevelopmentalstages.InBaF3cells,only
full-lengthanosmin-1withfourFnIIIdomains(PIWF4),butnot
truncatedPIWF1,wasfunctional,unlikeinFNC-B4.Thismaybe
because of the differences between the endogenous HSPGs
present in FNC-B4 cells and the exogenous heparin used in BaF3
assays. The exact HS structural requirement and its effect on the
activityofanosmin-1onFGFsandFGFRsotherthanthosetested
here are currently under investigation. Our observation that a
C172R mutation in the evolutionarily conserved WAP domain
blocks its function (Fig. 3B–D), together with previous reports
describingX-KS-relatedmutationsthatdisruptthedisulfidecore
motif (Oliveira et al., 2001; Sato et al., 2004), support the func-
tional and structural importance of this region. Our current in-
vestigation of the structural relationship among these molecules
should resolve such questions.
Our study is the first report describing a defined molecular
mechanism of anosmin-1 function and provides novel insights
intohowFGFR1signalingisregulatedandfine-tunedduringthe
olfactory GnRH system development. The present work also
identifies a potential mechanism underlying the link between
A-KS and X-KS. Furthermore, our data showing the dose-
dependent effect of anosmin-1 on the FGFR1 signal responses
provide a molecular basis for understanding the greater preva-
lenceofKSinmales.Infemales,theKAL-1genepartiallyescapes
X-inactivation (Franco et al., 1991), leading to a higher level of
anosmin-1 expression when compared with males; this may
compensateforpartialloss(haploinsufficiency)ofFGFR1signal-
ing in heterozygous females.
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